Press Releases

Active Biotech AB Interim Report January - September 2011
November 3, 2011 08:30 (CET)
Information regarding Active Biotech's candidate drug laquinimod
November 2, 2011 15:18 (CET)
INVESTIGATIONAL LAQUINIMOD DEMONSTRATES ITS POTENTIAL AS A NEW ORAL TREATMENT FOR RRMS
October 19, 2011 08:30 (CEST)
Active Biotech's Prostate Cancer Project TASQ Featured in Journal of Clinical Oncology
September 20, 2011 08:30 (CEST)
Active Biotech AB Interim Report January - June 2011
August 11, 2011 08:30 (CEST)
RESULTS OF PHASE III BRAVO TRIAL REINFORCE UNIQUE PROFILE OF LAQUINIMOD FOR MULTIPLE SCLEROSIS TREATMENT
August 1, 2011 13:41 (CEST)
Number of shares and votes in Active Biotech
June 30, 2011 08:30 (CEST)
Active Biotech to Present at the Jefferies 2011 Global Healthcare Conference
June 8, 2011 08:30 (CEST)
Number of shares and votes in Active Biotech
May 31, 2011 08:30 (CEST)
Active Biotech Presents Data regarding the 57-57 Project at EULAR
May 26, 2011 08:30 (CEST)